| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 76 |
| 1 | RIVAROXABAN | 75 |
| 2 | ASPIRIN | 68 |
| 3 | ASPIRIN 325 MG | 68 |
| 4 | ASPIRIN 81 MG | 68 |
| 5 | METHOTREXATE | 65 |
| 6 | SIMVASTATIN | 63 |
| 7 | DEXAMETHASONE | 61 |
| 8 | DEXAMETHASONE 1.5 MG | 60 |
| 9 | CLOPIDOGREL | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | INHALANT | 1 | 0.0227 |
| 2 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 3 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 4 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 5 | ADALIMUMAB-ATTO | 6 | 0.0037 |
| 6 | ERAVACYCLINE | 1 | 0.0034 |
| 7 | ROMIPLOSTIM | 44 | 0.0029 |
| 8 | DANAZOL | 8 | 0.0028 |
| 9 | CAPLACIZUMAB | 5 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 169 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 128 |
| 2 | Factor Xa Inhibitor [EPC] | 124 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 72 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 68 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 65 |
| 6 | Kinase Inhibitor [EPC] | 60 |
| 7 | Loop Diuretic [EPC] | 55 |
| 8 | Alkylating Drug [EPC] | 54 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 54 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 44 | 0.0029 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 3 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 13 | 0.0010 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 6 | Nonergot Dopamine Agonist [EPC] | 11 | 0.0007 |
| 7 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 8 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |